In the News

“I don’t accept in any way this very weak response by Minister Goodale and Minister [Jody] Wilson-Raybould that they somehow have their hands tied until October 17. There is no reason they couldn’t be working on this right now,” said Davies.

“Dr. Persaud led a group of seven physicians and academics who sent an open letter to the Prime Minister, the Health Minister and the Justice Minister in April, urging them to probe opioid manufacturers. Others who have called for such an investigation include former Ontario health minister Eric Hoskins and New Democratic MP Don Davies.”

Prime Minister Trudeau extends Canada’s military mission in Latvia – is it an effort to appease Donald Trump’s complaints on defence spending ahead of the NATO summit? MPs debate.

MPs Dan Vandal, Matt Jeneroux and Don Davies discuss whether provincial and federal governments should fill the Greyhound gap after the company announced it would be ending service for nearly all routes in Western Canada.

“New Democrat MP Don Davies, for example, attempted to pass a motion calling on the government to immediately pardon Canadians convicted of simple possession. The motion was defeated when it didn’t have the necessary unanimous consent.”

“New Democrat Don Davies says this is just another piece of proof that the us is no longer a safe place for Canada to send refugees and migrants.”

After Question Period on Wednesday, NDP MP Don Davies tried to pass a motion to “immediately provide pardons for those burdened by criminal records for cannabis offences that will soon be legal.”

“NDP MPs Don Davies and Jenny Kwan have both called on Prime Minister Justin Trudeau to publicly denounce the Trump administration’s separation tactics and cancel the Canada-U.S. Safe Third Country Agreement. “

Meanwhile, NDP MP Don Davies slammed the Red Chamber for making any changes to the bill.“I’m disappointed that the unelected Senate has seen fit to amend a bill that went through really rigorous examination in the House of Commons,” he said.

“Empirically driven, peer-reviewed studies have repeatedly demonstrated that universal, single-payer pharmacare will result in national savings in the range of $7-billion to $13-billion annually.”